Indegene Limited announced its financial results for the third quarter of fiscal year 2026, demonstrating robust revenue growth despite a decline in quarterly profit. The healthcare technology and analytics company reported these results for the quarter ended December 31, 2025, following a Board meeting held on January 29, 2026.

Financial Performance Overview

The company delivered strong top-line growth with revenue from operations increasing significantly on a year-over-year basis. However, profitability metrics showed mixed results across different time periods.

Nine-Month Performance

For the nine-month period ended December 31, 2025, Indegene showed consistent growth across key financial metrics compared to the corresponding period in the previous year.

Segment Performance and Restructuring

Effective October 1, 2025, the company reorganized its business segments by merging the Brand Activation Segment into Enterprise Commercial Solutions. Following this restructuring, Indegene now operates two primary reportable segments: Enterprise Commercial Solutions and Enterprise Medical Solutions.

Strategic Acquisitions

During the quarter, Indegene completed two significant acquisitions to strengthen its market position. On October 1, 2025, the company acquired 100% interest in BioPharm Parent Holdings Inc., a specialized marketing services agency, for ₹9,146 million (USD 104 million). Additionally, on October 16, 2025, Indegene acquired 100% interest in Warn & Co Limited, a transformation consulting firm, for ₹464 million (GBP 3.91 million).

Board Decisions and Corporate Actions

The Board of Directors approved several important matters during their January 29, 2026 meeting:

• Unaudited standalone and consolidated financial results for Q3FY26
• Amendment to the Anti-Sexual Harassment Policy
• Allotment of shares under RSU 2020 Plan
• Re-constitution of Board Committees

Committee Restructuring

Mr. Neeraj Bharadwaj, Non-Executive Independent Director, was inducted as a member of both the Nomination and Remuneration Committee and the Investment Committee effective January 29, 2026. The Nomination and Remuneration Committee now comprises six members, while the Investment Committee includes five members.

Financial Position

The company maintained a strong financial position with paid-up equity share capital of ₹480 million, consisting of shares with a face value of ₹2 each. Total comprehensive income for the quarter reached ₹1,222 million, including other comprehensive income of ₹193 million primarily from foreign exchange differences.

Indegene Limited has successfully concluded its postal ballot voting process on January 23, 2026, with shareholders overwhelmingly approving the appointment of Mr. Neeraj Bharadwaj as an Independent Director. The special resolution received strong support from the shareholder community, demonstrating confidence in the proposed board appointment.

Voting Results and Participation

The postal ballot process witnessed significant shareholder participation across different categories. The comprehensive voting results are detailed below:

The overall voting results show that 185805074 votes were cast in favour of the resolution, while 732944 votes were against, resulting in an approval rate of 99.61%.

Appointment Details and Process

The special resolution pertained to the appointment of Mr. Neeraj Bharadwaj (DIN: 01314963) as an Independent Director of the company. The postal ballot notice was issued on December 22, 2025, with the cut-off date for determining eligible shareholders set as December 12, 2025.

E-Voting Timeline and Compliance

The remote e-voting process remained open from Thursday, December 25, 2025, at 9:00 AM until Friday, January 23, 2026, at 5:00 PM. The voting was conducted in compliance with Sections 108 and 110 of the Companies Act, 2013, and Regulations 30 and 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Mr. Madhwesh K, Practicing Company Secretary (Membership No. A21477), served as the scrutinizer for the postal ballot process. The scrutinizer's report confirmed the validity of the voting process and results, with 1508177 votes from public institutions being classified as invalid.

Regulatory Compliance and Disclosure

The postal ballot results and scrutinizer's report have been made available at multiple locations for shareholder access:

• Company's registered office notice board
• Company website at www.indogene.com
• NSDL e-voting portal at www.evoting.nsdl.com

The company has fulfilled all regulatory requirements under the Companies Act, 2013, and SEBI regulations for conducting postal ballot through remote e-voting. The appointment of Mr. Neeraj Bharadwaj as Independent Director is now effective following the successful completion of the voting process.